Indication
Accessibility of Health Care
1 clinical trial
2 products
Clinical trial
A Phase II Acceptability Study of Oral Emtricitabine/Tenofovir Alafenamide (F/TAF) vs Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for the Prevention of HIV Acquisition in Adolescent Girls and Young Women (AGYW)Status: Active (not recruiting), Estimated PCD: 2023-12-13